These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 28501143)
21. New clinical criteria for the Alzheimer's disease spectrum. Petersen RC Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912 [TBL] [Abstract][Full Text] [Related]
22. Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course. Vöglein J; Ricard I; Noachtar S; Kukull WA; Dieterich M; Levin J; Danek A J Neurol; 2020 Oct; 267(10):2941-2948. PubMed ID: 32488295 [TBL] [Abstract][Full Text] [Related]
23. Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition. Hautecloque-Raysz G; Sellal F; Bousiges O; Phillipi N; Blanc F; Cretin B J Alzheimers Dis; 2023; 94(3):1057-1074. PubMed ID: 37355889 [TBL] [Abstract][Full Text] [Related]
24. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
25. From Mild Cognitive Impairment to Alzheimer's Disease: A New Perspective in the "Land" of Human Brain Reactivity and Connectivity. Rossini PM; Di Iorio R; Granata G; Miraglia F; Vecchio F J Alzheimers Dis; 2016 Jul; 53(4):1389-93. PubMed ID: 27540962 [TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease. Kvartsberg H; Duits FH; Ingelsson M; Andreasen N; Öhrfelt A; Andersson K; Brinkmalm G; Lannfelt L; Minthon L; Hansson O; Andreasson U; Teunissen CE; Scheltens P; Van der Flier WM; Zetterberg H; Portelius E; Blennow K Alzheimers Dement; 2015 Oct; 11(10):1180-90. PubMed ID: 25533203 [TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease. Cretin B Expert Opin Pharmacother; 2018 Aug; 19(11):1201-1209. PubMed ID: 30009650 [TBL] [Abstract][Full Text] [Related]
28. Seizure in Alzheimer's Disease: An Underestimated Phenomenon. Asadollahi M; Atazadeh M; Noroozian M Am J Alzheimers Dis Other Demen; 2019 Mar; 34(2):81-88. PubMed ID: 30595042 [TBL] [Abstract][Full Text] [Related]
29. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories. Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease. Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543 [TBL] [Abstract][Full Text] [Related]
31. Epileptic Seizures in Alzheimer Disease: A Review. Horváth A; Szűcs A; Barcs G; Noebels JL; Kamondi A Alzheimer Dis Assoc Disord; 2016; 30(2):186-92. PubMed ID: 26756385 [TBL] [Abstract][Full Text] [Related]
32. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study. Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420 [TBL] [Abstract][Full Text] [Related]
34. Epileptic seizures in clinically diagnosed Alzheimer's disease: report from a geriatric medicine population. Hommet C; Hureaux R; Barré J; Constans T; Berrut G Aging Clin Exp Res; 2007 Oct; 19(5):430-1. PubMed ID: 18007124 [TBL] [Abstract][Full Text] [Related]
35. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680 [TBL] [Abstract][Full Text] [Related]
36. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
37. A case of mild Alzheimer's disease accompanied by periodic synchronous discharges. Ishikawa H; Sekine A; Kanbayashi T; Shimizu T Clin EEG Neurosci; 2004 Jul; 35(3):165-7. PubMed ID: 15259624 [TBL] [Abstract][Full Text] [Related]
38. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment]. Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532 [TBL] [Abstract][Full Text] [Related]
39. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia. Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522 [TBL] [Abstract][Full Text] [Related]
40. Precuneus-Dominant Degeneration of Parietal Lobe Is at Risk of Epilepsy in Mild Alzheimer's Disease. Horvath A; Kiss M; Szucs A; Kamondi A Front Neurol; 2019; 10():878. PubMed ID: 31507508 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]